Literature DB >> 3044706

Potential involvement of retroviral elements in human dementias.

L Manuelidis1, G Murdoch, E E Manuelidis.   

Abstract

Creutzfeldt-Jakob disease (CJD) is a dementia of humans caused by a class of infectious agents with several biological properties similar to those of conventional viruses. The molecular nature of this group of agents is enigmatic, for neither an agent-specific nucleic acid nor a non-host protein has yet been identified. Recent transmissions of familial CJD dementias to rodents suggest that this class of agent can be integrated into the germline. Furthermore, tissue culture studies indicate that CJD causes transformation of cells in a manner reminiscent of slowly oncogenic retroviruses. Currently characterized retroviral-like elements include many forms that do not have 'typical' retroviral ultrastructural morphology; several forms are also known to be resistant to various types of standard physicochemical inactivation. We suggest that CJD agents are either constituted by retroviral-like nucleic acids or interact with endogenous retroviral sequences to elicit a slowly progressive disease of the central nervous system. Several overlapping properties between infectious CJD and 'non-infectious' dementias, such as Alzheimer's disease, implicate potential common pathogenic mechanisms.

Entities:  

Mesh:

Year:  1988        PMID: 3044706     DOI: 10.1002/9780470513613.ch8

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  23 in total

1.  Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; I Zaitsev; P Koni; Z Y Lu; R A Flavell; W Fritch
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease.

Authors:  Laura Manuelidis; Zhi Yun Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

Review 3.  The search for scrapie agent nucleic acid.

Authors:  J M Aiken; R F Marsh
Journal:  Microbiol Rev       Date:  1990-09

4.  Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes.

Authors:  T Sklaviadis; A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Potential retroviral RNAs in Creutzfeldt-Jakob disease.

Authors:  G H Murdoch; T Sklaviadis; E E Manuelidis; L Manuelidis
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Creutzfeldt-Jakob disease with intranuclear vacuolar inclusions: a biopsy case of negative light microscopic findings and successful animal transmission.

Authors:  J H Kim; B Lach; E E Manuelidis
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

7.  Physical properties of the Creutzfeldt-Jakob disease agent.

Authors:  T K Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  Nucleic acid binding proteins in highly purified Creutzfeldt-Jakob disease preparations.

Authors:  T Sklaviadis; A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.

Authors:  Laura Manuelidis; Ying Liu; Brian Mullins
Journal:  J Cell Biochem       Date:  2009-02-01       Impact factor: 4.429

10.  A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population.

Authors:  E E Manuelidis; L Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.